Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
CLS Transcript
Celestica Inc. (CLS:CA) Q4 2025 Earnings Call Transcript
Positive1-29
The earnings call indicates strong financial performance, with increased revenue and EPS guidance for 2025 and 2026. The company has a solid free cash flow outlook and a strong balance sheet. Despite slower growth guidance for 2026, management remains optimistic about future opportunities, particularly in AI/ML and networking. The Q&A section revealed cautious optimism and strategic investments in growth areas, which should positively impact the stock price. However, macroeconomic uncertainties pose potential risks. Overall, the sentiment leans positive, with expected stock price movement in the 2% to 8% range.
Celestica Inc. (CLS:CA) Q3 2025 Earnings Call Transcript
Positive10-28
The earnings call presents strong financial metrics, optimistic guidance, and strategic growth in AI/ML and networking, which are positive indicators. The Q&A section highlights robust customer commitments and future growth opportunities, despite some management reticence on specifics. The raised annual revenue and EPS outlooks, along with increased free cash flow, support a positive sentiment. The positive impact of the shareholder return plan and strong financial health further contribute to the positive outlook. However, the lack of specific guidance on some future aspects tempers the overall rating to 'Positive' rather than 'Strong positive.'
Celestica Inc. (CLS) Q2 2025 Earnings Call Transcript
Positive7-29
The earnings call summary and Q&A indicate strong financial performance, with raised revenue and EPS guidance, and significant growth in key segments like CCS. The management's confidence in sustaining growth, despite some uncertainties, and the positive sentiment from analysts support a positive outlook. However, the lack of long-term guidance and uncertainties in material availability slightly temper expectations. Overall, the short-term outlook is positive, likely leading to a stock price increase of 2% to 8% over the next two weeks.
Celestica Inc. (CLS) Q1 2025 Earnings Call Transcript
Positive4-25
The earnings call indicates strong financial performance, with a 20% revenue increase and a 45% rise in adjusted EPS, both exceeding guidance. The share repurchase plan is substantial, likely boosting shareholder confidence. Despite some uncertainties in the Q&A, such as tariff impacts and unclear guidance, the overall sentiment is positive due to robust growth, particularly in the CCS segment, and optimistic future guidance. The market is likely to react positively, with a potential 2% to 8% increase in stock price.
CLS Slides
CLS Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
